Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

NCT06126380 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant Rejection

Interventions

DRUG: AT-1501
DRUG: Tacrolimus

Sponsor

Eledon Pharmaceuticals